Related Experiment Video
Updated: Aug 20, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Polypunctosides E-K: seven new steroidal saponins from Polygonatum punctatum Royle ex Kunth and their nitric oxide
Tran Thi Thu Ha1,2, Nguyen Tien Dung3, Bui Huu Tai4,5
1Institute of Forestry Research and Development (IFRAD), Thai Nguyen University of Agriculture and Forestry, Thai Nguyen City, Vietnam. tranthithuhaptln@tuaf.edu.vn.
Abstract:
Polygonatum punctatum Royle ex Kunth is a high-value medicinal plant found in old natural forests. A phytochemical study on the roots of this plant led to the isolation of seven new steroidal saponins including four furostans (1-4) and three furospirostans (5-7). Their structures were elucidated as (25R)-26-O-(β-D-glucopyranosyl)-furost-5-ene-3β,17α,22α,26-tetraol 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (1), (25R)-26-O-(β-D-glucopyranosyl)-furost-5-ene-3β,14α,17α,22α,26-pentaol 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (2), (25R)-26-O-(β-D-glucopyranosyl)-furost-5-ene-22α-methoxy-3β,17α,26-triol 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (3), (25R)-26-O-(β-D-glucopyranosyl)-furost-5-ene-22α-methoxy-3β,17α,26-triol 3-O-[α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)]-[acetoxy-(→ 6)]-β-D-galactopyranoside (4), 26-O-(β-D-glucopyranosyl)-14α,17α-dihydroxynuatigenin 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (5), 26-O-(β-D-glucopyranosyl)-17α-hydroxynuatigenin 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (6), and 26-O-(β-D-glucopyranosyl)-14α-hydroxynuatigenin 3-O-α-L-arabinopyranosyl-(1 → 2)-β-D-glucopyranosyl-(1 → 4)-β-D-galactopyranoside (7) by extensive spectroscopic analyses, including infrared, high-resolution electrospray ionization mass spectrometry, and one- and two-dimensional nuclear magnetic resonance spectroscopy. Compounds 1-7 inhibited nitric oxide production in lipopolysaccharide activated RAW264.7 cells with IC50 values ranging from 41.5 ± 3.2 to 62.2 ± 3.7 µM, compared to 33.8 ± 2.6 µM for the positive control compound L-NMMA.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

